Blood Test Shows High Accuracy for Early Ovarian Cancer Detection
A new study demonstrates the capability of a blood test in detecting ovarian cancer up to three years prior to diagnosis in prospectively collected samples.
Read MorePosted by CLP Edit Staff | Oct 31, 2025 | Cancer |
A new study demonstrates the capability of a blood test in detecting ovarian cancer up to three years prior to diagnosis in prospectively collected samples.
Read MorePosted by CLP Edit Staff | Oct 24, 2025 | Breast |
The agreement focuses on clinical validation of ESR1 mutation detection assay for advanced breast cancer testing using ddPCR technology.
Read MorePosted by CLP Edit Staff | Oct 24, 2025 | Cancer |
PATHFINDER 2 study results indicate more than half of cancers detected by Galleri test were found in early stages, with three-quarters having no current screening options.
Read MorePosted by CLP Edit Staff | Oct 23, 2025 | Lung Cancer |
The permit enables the company to offer its PROphetNSCLC test to physicians and patients across New York State, completing nationwide availability.
Read MorePosted by CLP Edit Staff | Oct 23, 2025 | Cancer |
German laboratory brings tumor-informed MRD testing to European market through licensing agreement with Quest Diagnostics subsidiary.
Read More